Fig. 4.
Comparison of OS of the two main groups of PTCL: (A) n = 83; AIL, lymphoepithelioid, pleomorphic small-cell lymphoma patients and (B) n = 145 PML, immunoblastic patients.
Comparison of OS of the two main groups of PTCL: (A) n = 83; AIL, lymphoepithelioid, pleomorphic small-cell lymphoma patients and (B) n = 145 PML, immunoblastic patients.
